Barclays analyst Andrew Lazar maintained a Hold rating on McCormick & Company (MKC – Research Report) yesterday and set a price target of $71.00. The company’s shares closed yesterday at $65.78.
According to TipRanks, Lazar is a 4-star analyst with an average return of 5.9% and a 59.86% success rate. Lazar covers the Consumer Defensive sector, focusing on stocks such as BellRing Brands, The Hershey Company, and McCormick & Company.
In addition to Barclays, McCormick & Company also received a Hold from Consumer Edge Research’s Connor Rattigen in a report issued on January 22. However, on January 17, Goldman Sachs maintained a Sell rating on McCormick & Company (NYSE: MKC).
See today’s best-performing stocks on TipRanks >>
Based on McCormick & Company’s latest earnings release for the quarter ending August 31, the company reported a quarterly revenue of $1.68 billion and a net profit of $170.1 million. In comparison, last year the company earned a revenue of $1.6 billion and had a net profit of $222.9 million
Based on the recent corporate insider activity of 76 insiders, corporate insider sentiment is neutral on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
McCormick & Company (MKC) Company Description:
Founded in 1889, McCormick & Co., Inc. is a Maryland-based food company, which is engaged in the manufacturing, marketing and distribution of spices, seasoning mixes, condiments and other flavorful products to retail outlets, food manufacturers and foodservice businesses. It operates through the following two segments: Consumer and Flavor Solutions.
Read More on MKC:
- MKC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- McCormick downgraded to Equal Weight from Overweight at Consumer Edge
- McCormick price target lowered to $71 from $74 at Barclays
- McCormick price target lowered to $71 from $72 at Deutsche Bank
- McCormick price target lowered to $80 from $86 at BofA
